{"id":"W2162305848","doi":"10.1016/j.amjhyper.2005.03.060","title":"Vascular improvement with olmesartan medoxomil","year":2005,"lang":"en","type":"article","venue":"American Journal of Hypertension","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Medicine; Olmesartan; Myograph; Irbesartan; Blood pressure; Angiotensin II; Internal medicine; End organ damage; Angiotensin II receptor type 1; Urology; Cardiology; Endocrinology; Endothelium","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001779276,0.0002728806,0.0004139624,0.000123969,0.0001157235,0.0001840875,0.0001791579,0.0001624635,0.005230404],"category_scores_gemma":[0.0003754092,0.00007395737,0.0002534708,0.000078486,0.0001643799,0.0001546613,0.0001234884,0.001022781,0.0003759685],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001327682,"about_ca_system_score_gemma":0.0002120226,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001747882,"about_ca_topic_score_gemma":0.0003316041,"domain_scores_codex":[0.9999183,0.00002086577,0.000006746362,0.00001567235,0.00001317037,0.00002525085],"domain_scores_gemma":[0.9998633,0.00003612961,0.0000208561,0.00001616668,0.00001078471,0.00005288587],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1542433,0.02291693,0.004573483,0.0009337426,0.0003666537,0.0008796916,0.0001831132,0.00126055,0.4187891,0.00076257,0.003612961,0.391478],"study_design_scores_gemma":[0.07621349,0.6105539,0.1676524,0.0001454735,0.0009216678,0.002843252,0.0001993154,0.004275246,0.1024539,0.001119626,0.03355067,0.00007112804],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9916981,0.001436298,0.001018604,0.0003682764,0.0001946985,0.0001684568,0.0001847846,0.0001174266,0.004813362],"genre_scores_gemma":[0.9948913,0.0004721619,0.0006548789,0.0003290508,0.0001140458,0.00008204444,0.0002584642,0.000006486539,0.003191503],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005230404,"threshold_uncertainty_score":0.01749742,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01623044041513813,"score_gpt":0.2341840293638895,"score_spread":0.2179535889487514,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}